Pure Product-Derived Chiral Pyrrolidine-2,5-diones, Their Molecular Constructions and Conversion to Pharmacologically Essential Skeletons
The flexibility of the pure merchandise (2<i>S</i>,3<i>S</i>)- and (2<i>S</i>,3<i>R</i>)-3-hydroxy-5-oxotetrahydrofuran-2,3-dicarboxylic acids (<b>1</b> and <b>2</b>), remoted in giant quantities from tropical plant sources, has been demonstrated by the development of 3-substituted and three,4-disubstituted chiral pyrrolidine-2,5-diones.
- Absolutely the configurations of chiral pyrrolidine-2,5-diones have been ascertained utilizing chiroptical spectroscopic strategies and/or single-crystal XRD information. A mix of various response methods delivering a various matrix of fused heterocyclic ring methods is offered.
- The pyrrolo[2,1-<i>a</i>]isoquinoline alkaloid (+)-crispine A possesses a variety of pharmacological actions together with antidepressant, antiplatelet, antileukemic, and anticancer actions.
- The analogues of indolizino[8,7-<i>b</i>]indole alkaloids (+)- and (-)-harmicine present sturdy antileishmanial, antinociceptive, PDE5-inhibitory, antimalarial, and antiviral actions.
- The bicyclic furo[2,3-<i>b</i>]pyrrolo skeleton is current in lots of pure merchandise. Thus, the individuality of comparatively low cost, naturally occurring chiral 2-hydroxycitric acid lactones as chirons has been demonstrated by the development of some necessary molecular skeletons which are in any other case troublesome to synthesize.
PSMB8 Antibody |
|||
1-CSB-PA775839 | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
PSMB8 Antibody |
|||
E043134 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
1-CSB-PA018886GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
PSMB8 Antibody |
|||
1-CSB-PA018886LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
PSMB8 Antibody |
|||
E94054 | EnoGene | 100μg | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
E97340 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
E314816 | EnoGene | 100ug/200ul | EUR 295 |
Description: Available in various conjugation types. |
PSMB8 antibody |
|||
70R-13550 | Fitzgerald | 100 ul | EUR 550 |
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
PSMB8 antibody |
|||
70R-19589 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal PSMB8 antibody |
PSMB8 Antibody |
|||
1-CSB-PA116429 | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
PSMB8 antibody |
|||
BF0434 | Nova Lifetech | 100ug | EUR 355 |
PSMB8 Antibody |
|||
MBS7113266-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7113266-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7113266-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
MBS7129229-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7129229-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7129229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
MBS7129230-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7129230-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7129230-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 antibody |
|||
MBS9405580-01mL | MyBiosource | 0.1mL | EUR 420 |
PSMB8 antibody |
|||
MBS9405580-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
PSMB8 Antibody |
|||
MBS8500013-01mg | MyBiosource | 0.1mg | EUR 325 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
PSMB8 Antibody |
|||
MBS5312424-01mL | MyBiosource | 0.1mL | EUR 1070 |
PSMB8 Antibody |
|||
MBS5312424-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
PSMB8 Antibody |
|||
MBS9416351-01mL | MyBiosource | 0.1mL | EUR 305 |
PSMB8 Antibody |
|||
MBS9416351-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
PSMB8 Antibody |
|||
BF0434-100ul | Affinity Biosciences | 100ul | EUR 210 |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Antibody |
|||
BF0434-200ul | Affinity Biosciences | 200ul | Ask for price |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Antibody |
|||
BF0434-50ul | Affinity Biosciences | 50ul | EUR 150 |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Conjugated Antibody |
|||
C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
A73468 | EpiGentek | 50 μl | EUR 557 |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-006mL | MyBiosource | 0.06mL | EUR 190 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-012mL | MyBiosource | 0.12mL | EUR 265 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-02mL | MyBiosource | 0.2mL | EUR 415 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
PSMB8 Polyclonal Antibody |
|||
RD84433A-120uL | Reddot Biotech | 120μL | EUR 360 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
RD84433A-200uL | Reddot Biotech | 200μL | EUR 630 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
RD84433A-60uL | Reddot Biotech | 60μL | EUR 204 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Antibody (N-term) |
|||
MBS9213569-008mL | MyBiosource | 0.08mL | EUR 210 |
PSMB8 Antibody (N-term) |
|||
MBS9213569-04mL | MyBiosource | 0.4mL | EUR 430 |
PSMB8 Antibody (N-term) |
|||
MBS9213569-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
PSMB8 Antibody, HRP conjugated |
|||
1-CSB-PA018886LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody, FITC conjugated |
|||
1-CSB-PA018886LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
OACD05288-1ML - PSMB8 Antibody |
|||
OACD05288-1ML | Aviva Systems Biology | 1ml | EUR 649 |
OACD05289-1ML - PSMB8 Antibody |
|||
OACD05289-1ML | Aviva Systems Biology | 1ml | EUR 659 |
OACD05290-1ML - PSMB8 Antibody |
|||
OACD05290-1ML | Aviva Systems Biology | 1ml | EUR 639 |
PSMB8 Antibody, FITC Conjugated |
|||
MBS7113268-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, FITC Conjugated |
|||
MBS7113268-01mL | MyBiosource | 0.1mL | EUR 270 |
Synthesis and Spectroscopic Evaluation of Piperine- and Piperlongumine-Impressed Pure Product Scaffolds and Their Molecular Docking with IL-1β and NF-κB Proteins
Impressed by the exceptional bioactivities exhibited by the pure merchandise, piperine and piperlongumine, we synthesised eight pure product-inspired analogues to additional examine their constructions.
For the primary time, we confirmed the construction of the important thing cyclised dihydropyrazolecarbothioamide piperine analogues together with the usage of two-dimensional (2D) <sup>15</sup>N-based spectroscopy nuclear magnetic resonance (NMR) spectroscopy. Prior investigations demonstrated promising outcomes from these scaffolds for the inhibition of inflammatory response by way of downregulation of the IL-1β and NF-κB pathway.
Nevertheless, the molecular interplay of those molecules with their protein targets stays unknown. Ab initio calculations revealed the digital density operate map of the molecules, exhibiting the results of structural modification within the digital construction.
Lastly, molecular interactions between the synthesized molecules and the proteins IL-1β and NF-κB had been achieved.
Docking outcomes confirmed that each one the analogues work together within the DNA binding web site of NF-κB with greater affinity in comparison with the pure merchandise and, except for <b>9a</b> and <b>9b,</b> have greater affinity than the pure merchandise for the binding web site of IL-1β. Specificity for the molecular recognition of <b>3a</b>, <b>3c</b> and <b>9b</b> with IL-1β by cation-π interactions was decided.
These outcomes revealed <b>3a</b>, <b>3c</b>, <b>4a</b>, <b>4c</b> and <b>10</b> as probably the most promising molecules to be evaluated as IL-1β and NF-κB inhibitors.
Key phrases: molecular docking; piperine; piperlongumine
First molecular detection of Coxiella burnetii in Brazilian artisanal cheese: a uncared for meals security hazard in ready-to-eat raw-milk product
Background: International publications on Q fever have elevated after the 2007 epidemic within the Netherlands. Nevertheless, the epidemiology of Q fever/coxiellosis in Brazil continues to be poorly understood. Accordingly, there have been few research investigating the presence of Coxiella burnetii in dairy merchandise world wide, particularly in Brazil, the place consumption of contemporary cheese comprised of raw-milk may be very excessive.
Goal: This research was a random survey to evaluate the prevalence of C. burnetii by PCR in conventional Minas artisanal cheese from the Serro microregion, Brazil, which is manufactured from bovine raw-milk.
Strategies: DNA extracted from 53 cheese samples had been analyzed by nested PCR with C. burnetii-specific primers and the merchandise confirmed by DNA sequencing.
Outcomes: Out of the 53 cheese samples 5 (9.43%) had been C. burnetii DNA-positive, every coming from one of many respective randomly chosen manufacturing agroindustries. Primarily based on our outcomes, it’s estimated that 1.62 tons/day of ready-to-eat cheese comprised of raw-milk from a complete of 16.2 tons produced every day within the research area are contaminated with C. burnetii.
Conclusion: To our data, that is the primary report of extremely heat-resistant zoonotic pathogen in raw-milk Brazilian artisanal cheese.
This meals security hazard has been fully uncared for in ready-to-eat raw-milk Brazilian artisanal cheese and will suggest potential threats to shoppers, since C. burnetii survives in artisanal cheese submitted to lengthy ripening intervals.
Thus, this work established random and consultant baseline prevalence of C. burnetii on this meals product in Brazil.
Additional epidemiological research, monitoring developments and setting management targets are warranted. Lastly, these outcomes level out the significance of together with C. burnetii in animal and public well being surveillance packages.
Key phrases: Brazil; Coxiella burnetii; Meals security; Minas artisanal cheese; Zoonosi
PSMB8 Antibody |
|||
1-CSB-PA775839 | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
PSMB8 Antibody |
|||
E043134 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
1-CSB-PA018886GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
PSMB8 Antibody |
|||
1-CSB-PA018886LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
PSMB8 Antibody |
|||
E94054 | EnoGene | 100μg | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
E97340 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
E314816 | EnoGene | 100ug/200ul | EUR 295 |
Description: Available in various conjugation types. |
PSMB8 antibody |
|||
70R-13550 | Fitzgerald | 100 ul | EUR 550 |
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
PSMB8 antibody |
|||
70R-19589 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal PSMB8 antibody |
PSMB8 Antibody |
|||
1-CSB-PA116429 | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
PSMB8 antibody |
|||
BF0434 | Nova Lifetech | 100ug | EUR 355 |
PSMB8 Antibody |
|||
MBS7113266-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7113266-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7113266-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
MBS7129229-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7129229-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7129229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
MBS7129230-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7129230-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7129230-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 antibody |
|||
MBS9405580-01mL | MyBiosource | 0.1mL | EUR 420 |
PSMB8 antibody |
|||
MBS9405580-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
PSMB8 Antibody |
|||
MBS8500013-01mg | MyBiosource | 0.1mg | EUR 325 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
PSMB8 Antibody |
|||
MBS5312424-01mL | MyBiosource | 0.1mL | EUR 1070 |
PSMB8 Antibody |
|||
MBS5312424-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
PSMB8 Antibody |
|||
MBS9416351-01mL | MyBiosource | 0.1mL | EUR 305 |
PSMB8 Antibody |
|||
MBS9416351-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
PSMB8 Antibody |
|||
BF0434-100ul | Affinity Biosciences | 100ul | EUR 210 |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Antibody |
|||
BF0434-200ul | Affinity Biosciences | 200ul | Ask for price |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Antibody |
|||
BF0434-50ul | Affinity Biosciences | 50ul | EUR 150 |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Conjugated Antibody |
|||
C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
A73468 | EpiGentek | 50 μl | EUR 557 |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-006mL | MyBiosource | 0.06mL | EUR 190 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-012mL | MyBiosource | 0.12mL | EUR 265 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-02mL | MyBiosource | 0.2mL | EUR 415 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
PSMB8 Polyclonal Antibody |
|||
RD84433A-120uL | Reddot Biotech | 120μL | EUR 360 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
RD84433A-200uL | Reddot Biotech | 200μL | EUR 630 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
RD84433A-60uL | Reddot Biotech | 60μL | EUR 204 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Antibody (N-term) |
|||
MBS9213569-008mL | MyBiosource | 0.08mL | EUR 210 |
PSMB8 Antibody (N-term) |
|||
MBS9213569-04mL | MyBiosource | 0.4mL | EUR 430 |
PSMB8 Antibody (N-term) |
|||
MBS9213569-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
PSMB8 Antibody, HRP conjugated |
|||
1-CSB-PA018886LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody, HRP Conjugated |
|||
MBS7113267-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody, FITC conjugated |
|||
1-CSB-PA018886LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
OACD05288-1ML - PSMB8 Antibody |
|||
OACD05288-1ML | Aviva Systems Biology | 1ml | EUR 649 |
OACD05289-1ML - PSMB8 Antibody |
|||
OACD05289-1ML | Aviva Systems Biology | 1ml | EUR 659 |
OACD05290-1ML - PSMB8 Antibody |
|||
OACD05290-1ML | Aviva Systems Biology | 1ml | EUR 639 |
PSMB8 Antibody, FITC Conjugated |
|||
MBS7113268-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, FITC Conjugated |
|||
MBS7113268-01mL | MyBiosource | 0.1mL | EUR 270 |